Altre lingue HLB bioStep Co.,Ltd.

Azioni

A278650

KR7278650007

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 05/07/2024			Variaz. 5gg	Var. 1 gen.
3.050 ^KRW	+15,75%		+33,48%	-1,29%

20/05	HLB bioStep Co.,Ltd. (KOSDAQ:A278650) annuncia un riacquisto di azioni per un valore di 3.000 milioni di KRW.	CI
20/05	HLB bioStep Co.,Ltd. autorizza un Piano di riacquisto.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	20/05
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.	20/05
Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on February 8, 2024.	17/05
HLB bioStep Co.,Ltd. announced that it has received KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.	09/05
HLB bioStep Co.,Ltd. announced that it expects to receive KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.	25/04
Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on December 4, 2023.	08/03
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	08/02
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.	08/02
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	04/12
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.	04/12
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors	21/06/23
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.	21/06/23
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors	13/03/23
HLB SCIENCE Inc. announced that it has received KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.	09/02/23
HLB SCIENCE Inc. announced that it expects to receive KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.	01/02/23
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors	01/02/23
KNOTUS Co.,Ltd's Equity Buyback announced on March 13, 2020 has expired with 71,714 shares, representing 0.98% for KRW 960.15 million.	12/03/22
KNOTUS Co.,Ltd announced that it has received KRW 81.1 billion in funding	13/01/22
HLB Co., Ltd. entered into a contract to acquire 18.4% stake in KNOTUS Co.,Ltd from Jeong In-seong and Kim Do-hyung for KRW 56.2 billion.	27/12/21
KNOTUS Co.,Ltd announced that it expects to receive KRW 94.6 billion in funding	27/12/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue HLB bioStep Co.,Ltd.

Azioni

A278650

KR7278650007

Altre lingue

Filtri